# Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

> **NCT00462397** · PHASE2 · UNKNOWN · sponsor: **University College London Hospitals** · enrollment: 50 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** paclitaxel
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00462397
- **Lead sponsor:** University College London Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462397, "Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00462397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*